Mycophenolate mofetil and Theophyl drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mycophenolate mofetil (mycophenolate mofetil) and Theophyl (theophylline). Common drug interactions include overdose among females and headache among males.
The phase IV clinical study analyzes what interactions people have when they take Mycophenolate mofetil and Theophyl. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Mycophenolate mofetil?
Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.
What is Theophyl?
Theophyl has active ingredients of theophylline. eHealthMe is studying from 19,174 Theophyl users. Check the latest studies of Theophyl.
22 people who take Mycophenolate mofetil and Theophyl together, and have interactions are studied.

What are the common drug interactions of Mycophenolate Mofetil and Theophyl, by gender? *:
female:
- Overdose
- Bacterial infection
- Blood glucose increased
- Cellulitis (infection under the skin)
- Erythema (redness of the skin)
- Haemoglobin decreased
- Pyrexia (fever)
- Abdominal discomfort
- Abdominal pain
- Adverse drug reaction
male:
- Headache (pain in head)
- Muscle twitching
- Subdural haemorrhage (bleeding between the skull and the surface of the brain)
- Urinary incontinence (inability to control the flow of urine and involuntary urination)
- Vertigo
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Overdose
- Pneumonia
What are the common drug interactions of Mycophenolate Mofetil and Theophyl, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Overdose
30-39:
- Muscle twitching
- Cerebral haemorrhage (bleeding within the brain)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Headache (pain in head)
- Lethargy (tiredness)
- Loss of consciousness
- Memory impairment
- Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
- Oxygen saturation decreased
- Subdural haematoma (blood collects between the skull and the surface of the brain)
40-49:
- Bradycardia (abnormally slow heart action)
- Cardiac arrest
- Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
50-59:
- Blood creatine phosphokinase increased
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Death
- Hepatocellular damage (liver damage)
- Lung function decreased
- Renal injury (kidney injury)
60+:
- Cerebral infarction (less blood supply to brain resulting tissue damage)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Abdominal discomfort
- Abdominal pain
- Adverse drug reaction
- Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
- Coma (state of unconsciousness lasting more than six hours)
- Diarrhoea haemorrhagic (bloody diarrhoea)
- Gastrointestinal infection (infection of stomach and intestine)
- Headache (pain in head)
What are the existing conditions these people have? *
- Bradycardia (abnormally slow heart action): 7 people, 31.82%
- Procedural Vomiting: 4 people, 18.18%
- Procedural Nausea: 4 people, 18.18%
- Immunodeficiency Disorders: 3 people, 13.64%
- Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 13.64%
- Asthma: 3 people, 13.64%
- Post Procedural Constipation: 2 people, 9.09%
- Post Procedural Complication: 2 people, 9.09%
- Indigestion: 2 people, 9.09%
- High Blood Pressure: 2 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Mycophenolate mofetil and Theophyl?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Mycophenolate mofetil (93,460 reports)
- Theophyl (19,174 reports)
Browse all drug interactions of Mycophenolate mofetil and Theophyl:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mycophenolate mofetil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Theophyl:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mycophenolate mofetil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Theophyl and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on mycophenolate mofetil and theophylline (the active ingredients of Mycophenolate mofetil and Theophyl, respectively), and Mycophenolate mofetil and Theophyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Unituxin cause Drowsiness? - 25 seconds ago
- Could Prednisone cause Necrosis? - 36 seconds ago
- Could Duloxetine Hydrochloride cause Renal Function Test Abnormal? - 43 seconds ago
- Could Everolimus cause Iron Deficiency Anaemia? - 45 seconds ago
- Could Selenium cause B-Lymphocyte Count Decreased? - 46 seconds ago
- Could Keytruda cause Unilateral Hydronephrosis? - 54 seconds ago
- Could Moviprep cause Abdominal Pain? - a minute ago
- Could Arava cause Monocyte Count Decreased? - a minute ago
- Could Baldrian cause Fatigue? - a minute ago
- Could Claritin-D 24 Hour cause Sleep Disorder? - a minute ago